Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors

Reduction of Immunosuppression as Initial Therapy for Posttransplantation Lymphoproliferative Disorder★

(2011) R. Reshef et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

(2011) R. Trappe et al.   HAEMATOLOGICA

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

(2011) Bertrand Coiffier et al.   LANCET ONCOLOGY

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

(2011) Ralf Trappe et al.   LANCET ONCOLOGY

Novel Strategies in Immunosuppression: Issues in Perspective

(2011) Allison Webber et al.   TRANSPLANTATION

Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States

(2010) Scott C. Quinlan et al.   AMERICAN JOURNAL OF HEMATOLOGY

Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative Disorder

(2010) M. L. Gulley et al.   CLINICAL MICROBIOLOGY REVIEWS

Treatment advances in posttransplant lymphoproliferative disease

(2010) Courtney D DiNardo et al.   CURRENT OPINION IN HEMATOLOGY

Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy*

(2010) Sari Riihijärvi et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Multicenter Analysis of 80 Solid Organ Transplantation Recipients With Post-Transplantation Lymphoproliferative Disease: Outcomes and Prognostic Factors in the Modern Era

(2010) Andrew M. Evens et al.   JOURNAL OF CLINICAL ONCOLOGY

EBV viral load detection in clinical virology

(2010) Barbara Gärtner et al.   JOURNAL OF CLINICAL VIROLOGY

Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation

(2009) O. Landgren et al.   BLOOD

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

(2009) Lode J. Swinnen et al.   TRANSPLANTATION

A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation

(2008) Matthew J. Hourigan et al.   BRITISH JOURNAL OF HAEMATOLOGY